These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 16749606

  • 1. Drop attacks and vertical vertigo after transtympanic gentamicin: diagnosis and management.
    Dallan I, Bruschini L, Nacci A, Bignami M, Casani AP.
    Acta Otorhinolaryngol Ital; 2005 Dec; 25(6):370-3. PubMed ID: 16749606
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.
    Liu YF, Renk E, Rauch SD, Xu HX.
    Otol Neurotol; 2017 Aug; 38(7):1005-1009. PubMed ID: 28538472
    [Abstract] [Full Text] [Related]

  • 3. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D, Patrikakos G.
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [Abstract] [Full Text] [Related]

  • 4. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
    Pierchała K, Krzeska-Malinowska I, Kowalska M, Bartoszewicz R, Niemczyk K.
    Otolaryngol Pol; 2005 Jan; 59(3):409-13. PubMed ID: 16117399
    [Abstract] [Full Text] [Related]

  • 5. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I.
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [Abstract] [Full Text] [Related]

  • 6. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K, Schönfeld U, Clarke AH.
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [Abstract] [Full Text] [Related]

  • 7. [Intratympanic gentamicin in patients with Ménière's disease: analysis of our protocol].
    Martín Sanz E, Pérez Fernández N.
    Acta Otorrinolaringol Esp; 2004 Dec; 55(6):270-6. PubMed ID: 15491114
    [Abstract] [Full Text] [Related]

  • 8. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
    Rah YC, Han JJ, Park J, Choi BY, Koo JW.
    Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
    [Abstract] [Full Text] [Related]

  • 9. Refractory episodic vertigo: role of intratympanic gentamicin and vestibular evoked myogenic potentials.
    Celis-Aguilar E, Hinojosa-González R, Vales-Hidalgo O, Coutinho-Toledo H.
    Braz J Otorhinolaryngol; 2016 Apr; 82(6):668-673. PubMed ID: 27068887
    [Abstract] [Full Text] [Related]

  • 10. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D, Wolf M, Kronenberg J.
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [Abstract] [Full Text] [Related]

  • 11. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT, Minor LB, Della Santina CC, Carey JP.
    Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
    [Abstract] [Full Text] [Related]

  • 12. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA, Chen DA, Arriaga MA.
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [Abstract] [Full Text] [Related]

  • 13. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 14. Delayed onset of ototoxic effects of gentamicin in treatment of Menière's disease. Rationale for extremely low dose therapy.
    Magnusson M, Padoan S.
    Acta Otolaryngol; 1991 Jul; 111(4):671-6. PubMed ID: 1950529
    [Abstract] [Full Text] [Related]

  • 15. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J.
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [Abstract] [Full Text] [Related]

  • 16. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L, Jariengprasert C, Ruencharopen S, Orathai P.
    J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
    [Abstract] [Full Text] [Related]

  • 17. Intratympanic gentamicin in bilateral Menière's disease.
    Pyykkö I, Ishizaki H, Kaasinen S, Aalto H.
    Otolaryngol Head Neck Surg; 1994 Feb; 110(2):162-7. PubMed ID: 8108151
    [Abstract] [Full Text] [Related]

  • 18. Transtympanic gentamicin perfusion for the treatment of Meniere's disease.
    Schwaber MK.
    Otolaryngol Clin North Am; 2002 Apr; 35(2):287-95, vi. PubMed ID: 12391619
    [Abstract] [Full Text] [Related]

  • 19. Histopathology of the vestibular end organs after intratympanic gentamicin failure for Meniere's disease.
    Ishiyama G, Lopez I, Baloh RW, Ishiyama A.
    Acta Otolaryngol; 2007 Jan; 127(1):34-40. PubMed ID: 17364327
    [Abstract] [Full Text] [Related]

  • 20. Inner ear changes with intracochlear gentamicin administration in Guinea pigs.
    Okuda T, Sugahara K, Shimogori H, Yamashita H.
    Laryngoscope; 2004 Apr; 114(4):694-7. PubMed ID: 15064626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.